Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-010825

Director sold 6,964 shares at an average $24.11 ($167,888)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Heyman Richard A. · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-11 Sale : show line 1 in the form 10b5-1 −5,045 $25.03 $126,279 138.43 D
2024-04-15 Sale : show line 2 in the form 10b5-1 −1,190 $19.94 $23,729 137,235 D
2024-04-15 Sale : show line 3 in the form 10b5-1 −80 $20.68 $1,654 137,155 D
2024-04-11 Sale : show line 4 in the form 10b5-1 −649 $25.00 $16,225 28,567 I
Open-market sales · 6,964 sh · avg $24.11 · $167,888
Loading xslF345X05/form4-04152024_110425.xml…